(ii) As a delayed regimen, the therapy (BPC 157 or saline (5 mL/kg)) was given as an intragastric administration at 4.30 h of ligation time for assessment at 5 h of ligation time, or BPC 157 as an oral administration, given continuously in drinking water from 5 h of ligation time until the sacrifice at 24 h of ligation time (0.16 g/mL/rat, 0.16 ng/mL/rat) while controls received drinking water only (12 mL/day/rat)
Patients with active infections in the affected joint, certain autoimmune conditions, or active malignancies may not be candidates for peptide therapy
Patients seeking a science-backed, physician-led approach to metabolic health are discovering that tirzepatide offers a level of efficacy that few treatments can match
The study concluded that both topical and oral glutathione are effective skin-lightening agents, with the combination therapy potentially offering superior results
Update: Glossy added a comment from Jonathan Swerdlin, co-founder and CEO at Function, after this storys initial publication.